Table 2. Broth Microdilution AST Results for ADC Variants in pBCSK(−) E. coli DH10B in This Studya.
| β-lactamase | CAZ | CAZ + MB076 | CTX | CTX + MB076 | TOL | TOL + MB076 | FDC | FDC + MB076 | FEP |
|---|---|---|---|---|---|---|---|---|---|
| ADC-7 | 64 | 4 | 64 | 1 | 8 | 1 | 0.5 | 0.5 | 0.25 |
| ADC-30 | 128 | 2 | 64 | 2 | 8 | 0.5 | 0.5 | 0.5 | 0.25 |
| ADC-33 | 2048 | 16 | 128 | 1 | 256 | 16 | 2 | 0.5 | 0.5 |
| ADC-162 | 128 | 4 | 64 | 2 | 16 | 1 | 0.5 | 0.25 | 0.25 |
| ADC-212 | 512 | 64 | 128 | 16 | 256 | 16 | 1 | 0.5 | 0.5 |
| ADC-219 | 256 | 16 | 16 | 2 | 128 | 8 | 1 | 0.5 | 0.12 |
MICs in mg/L. Antimicrobial susceptibility tests were interpreted according to 2021 CLSI criteria for Enterobacterales: for ceftazidime (CAZ) and cefiderocol (FDC), MIC ≤ 4 mg/L is susceptible (S), MIC = 8 mg/L is intermediate (I), and MIC ≥ 16 mg/L is resistant (R); for cefotaxime (CTX) MIC ≤ 1 mg/L is S, MIC = 2 mg/L is I, and MIC ≥ 4 mg/L is R; for ceftolozane (TOL), no CLSI breakpoints have been defined. Most isolates were highly susceptible to cefepime (FEP, ≤0.25 mg/L, S) and were therefore not tested with MB076. MB076 was used at a fixed concentration of 10 mg/L.